Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 11, 2011 - Issue 7
Submit an article Journal homepage
327
Views
16
CrossRef citations to date
0
Altmetric
Drug Profile

Pramipexole for the treatment of early Parkinson’s disease

Santiago Perez-Lloret Departments of Clinical Pharmacology and Neurosciences, University Hospital and University of Toulouse, France and INSERM CIC-9023 and UMR-825, Toulouse, France; Department of Clinical Pharmacology, Faculty of Medicine, 37 Allées Jules Guesde, 31000, Toulouse, France; Clinical Pharmacology Center, Raul Carrea Institute for Neurological Research, Buenos Aires, Argentina; Departments of Clinical Pharmacology and Neurosciences, University Hospital and University of Toulouse, France and INSERM CIC-9023 and UMR-825, Toulouse, France; Department of Clinical Pharmacology, Faculty of Medicine, 37 Allées Jules Guesde, 31000, Toulouse, France; Clinical Pharmacology Center, Raul Carrea Institute for Neurological Research, Buenos Aires, Argentina
,
María Verónica Rey Departments of Clinical Pharmacology and Neurosciences, University Hospital and University of Toulouse, France and INSERM CIC-9023 and UMR-825, Toulouse, France; Department of Clinical Pharmacology, Faculty of Medicine, 37 Allées Jules Guesde, 31000, Toulouse, France; Departments of Clinical Pharmacology and Neurosciences, University Hospital and University of Toulouse, France and INSERM CIC-9023 and UMR-825, Toulouse, France; Department of Clinical Pharmacology, Faculty of Medicine, 37 Allées Jules Guesde, 31000, Toulouse, France
,
Luca Ratti Departments of Clinical Pharmacology and Neurosciences, University Hospital and University of Toulouse, France and INSERM CIC-9023 and UMR-825, Toulouse, France; Department of Clinical Pharmacology, Faculty of Medicine, 37 Allées Jules Guesde, 31000, Toulouse, France; Departments of Clinical Pharmacology and Neurosciences, University Hospital and University of Toulouse, France and INSERM CIC-9023 and UMR-825, Toulouse, France; Department of Clinical Pharmacology, Faculty of Medicine, 37 Allées Jules Guesde, 31000, Toulouse, France
&
Olivier Rascol Departments of Clinical Pharmacology and Neurosciences, University Hospital and University of Toulouse, France and INSERM CIC-9023 and UMR-825, Toulouse, France; Department of Clinical Pharmacology, Faculty of Medicine, 37 Allées Jules Guesde, 31000, Toulouse, France;[email protected]
Pages 925-935 | Published online: 09 Jan 2014

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Santiago Perez-Lloret, María Verónica Rey, James Crispo, Daniel Krewski, Marise Lapeyre-Mestre, Jean-Louis Montastruc & Olivier Rascol. (2014) Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients. Expert Opinion on Drug Safety 13:3, pages 351-360.
Read now

Articles from other publishers (15)

A. Poisson & S. Thobois. (2022) Allucinazioni e morbo di Parkinson. EMC - Neurologia 22:1, pages 1-7.
Crossref
Ehsan Ziaei, Parisa Emami Ardestani & Ahmad Chitsaz. (2022) Comparison of pramipexole and citalopram in the treatment of depression in Parkinson's disease: A randomized parallel-group trial. Journal of Research in Medical Sciences 27:1, pages 55.
Crossref
Nazlı Turan Yücel, Derya Osmaniye, Ümmühan Kandemir, Asaf Evrim Evren, Özgür Devrim Can & Ümide Demir Özkay. (2021) Synthesis and Antinociceptive Effect of Some Thiazole-Piperazine Derivatives: Involvement of Opioidergic System in the Activity. Molecules 26:11, pages 3350.
Crossref
Dong-Xin Wang, Ying Yang, Xiao-Song Huang, Jia-Yu Tang, Xi Zhang, Hong-Xing Huang, Bin Zhou, Bo Liu, Hui-Qiong Xiao, Xiao-Hui Li, Ping Yang, Shu-Cheng Zou, Kun Liu, Xiao-Ye Wang & Xiao-Song Li. (2021) Pramipexole attenuates neuronal injury in Parkinson's disease by targeting miR-96 to activate BNIP3-mediated mitophagy. Neurochemistry International 146, pages 104972.
Crossref
Sara Silva, António Almeida & Nuno Vale. (2021) Importance of Nanoparticles for the Delivery of Antiparkinsonian Drugs. Pharmaceutics 13:4, pages 508.
Crossref
Yan Wang, De-Qi Jiang, Cheng-Shu Lu, Ming-Xing Li & Li-Lin Jiang. (2021) Efficacy and safety of combination therapy with pramipexole and levodopa vs levodopa monotherapy in patients with Parkinson disease. Medicine 100:44, pages e27511.
Crossref
Sean M. Wilson, Madeline G. Wurst, Michael F. Whatley & R. Nathan Daniels. (2020) Classics in Chemical Neuroscience: Pramipexole. ACS Chemical Neuroscience 11:17, pages 2506-2512.
Crossref
Mohammad Hossein Abbasi, Sara Esmaeili, Seyed Amirhassan Habibi & Gholam Ali Shahidi. (2020) Dilemma in Parkinson’s Treatment; Levodopa Monotherapy May be the Best Choice. Journal of Clinical Neuroscience 79, pages 219-223.
Crossref
Nicolas Venisse, Sandrine Venisse & Antoine Dupuis. 2018. Pharmacie Clinique et Thérapeutique. Pharmacie Clinique et Thérapeutique 611 625.e1 .
Tianwen Hu, Feipu Yang, Tao Jiang, Weiming Chen, Jian Zhang, Jianfeng Li, Xiangrui Jiang & Jingshan Shen. (2016) Synthesis of Impurities of Pramipexole Dihydrochloride. Organic Process Research & Development 20:11, pages 1899-1905.
Crossref
Mine Silindir & A. Yekta Ozer. (2014) The benefits of pramipexole selection in the treatment of Parkinson’s disease. Neurological Sciences 35:10, pages 1505-1511.
Crossref
Karen M. Smith, Susan E. Browne, Srinivasan Jayaraman, Carina J. Bleickardt, Lisa M. Hodge, Edward Lis, Leon Yao, Sunday L. Rittle, Nathalie Innocent, Deborra E. Mullins, George Boykow, Ian J. Reynolds, David Hill, Eric M. Parker & Robert A. Hodgson. (2014) Effects of the selective adenosine A2A receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice. European Journal of Pharmacology 728, pages 31-38.
Crossref
A. Poisson & S. Thobois. (2014) Allucinazioni e malattia di Parkinson. EMC - Neurologia 14:2, pages 1-5.
Crossref
Jesse Bastiaens, Benjamin J. Dorfman, Paul J. Christos & Melissa J. Nirenberg. (2013) Prospective cohort study of impulse control disorders in Parkinson's disease. Movement Disorders 28:3, pages 327-333.
Crossref
James P. Kelleher, Franca Centorrino, Nancy A. Huxley, John A. Bates, Jennifer Kidwell Drake, Samy Egli & Ross J. Baldessarini. (2012) Pilot randomized, controlled trial of pramipexole to augment antipsychotic treatment. European Neuropsychopharmacology 22:6, pages 415-418.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.